4246 Hypercoagulability promotes atrial fibrosis and fibrillation

Autor: Ulrich Schotten, Sander Verheule, Anne-Margreet De Jong, Hetty De Boer, Alexander Maass, Lau, Dennis H., Michiel Rienstra, Pieter Kamphuisen, Hugo Ten Cate, Crijns, Harry J. G., Isabelle Van Gelder, Zonneveld, Anton J., Henri Spronk
Přispěvatelé: Cardiovascular Centre (CVC), Vascular Ageing Programme (VAP)
Předmět:
Zdroj: University of Groningen
Heart Rhythm, 11(5), 6-7. ELSEVIER SCIENCE INC
ISSN: 1547-5271
Popis: Introduction: Atrial fibrillation (AF) induces a hypercoagulable state. Coagulation factors provoke pro-fibrotic, pro-hypertrophic, and pro-inflammatory responses in a variety of tissues by stimulation of protease-activated receptors. We studied whether hypercoagulability causes atrial fibrosis and promotes AF. Methods and Results: In mice with enhanced thrombin activity (TMpro/pro), inducibility of AF episodes induced by burst pacing was higher and duration of AF episodes was longer compared to wild type (episodes > 2s in 6 out of 10 versus 0 out of 10 in wild type). In isolated rat cardiac fibroblasts, thrombin (0.05units/ ml) enhanced the phosphorylation of the pro-fibrotic signaling molecules Akt and Erk, and increased expression of tumor growth factor β1 (2.7fold) and the pro-inflammatory factor MCP-1 (6.1fold). Thrombin also increased the incorporation of 3H-proline suggesting enhanced collagen synthesis by cardiac fibroblasts (2.5fold). All effects could be prevented by the direct thrombin inhibitor dabigatran. In 6 goats with persistent AF treated with fraxiparine, endomysial fibrosis and the complexity of the AF substrate were less pronounced compared to control animals (maximal conduction time 23.3±3.1ms in control versus 15.7±2.1ms in fraxiparine, p
Databáze: OpenAIRE